All articles tagged with #stock surge
Snowflake's shares surged about 36.5% in intraday trading to around $239, buoyed by rising enterprise AI demand and a strategic partnership with AWS, underscoring Snowflake's growing position as an AI-enabled cloud data warehouse play.
Moderna’s shares jumped about 14% after news of early hantavirus vaccine research with the U.S. Army and Korea University, though executives say the work is in its infancy and not close to a vaccine. Experts note funding has been limited because hantavirus outbreaks are rare, suggesting a vaccine could be years or even a decade away. Wall Street shows a Hold consensus on MRNA with a $41.75 target implying potential downside, so the stock move reflects long‑term research interest rather than near‑term product prospects.
Nvidia stock rose about 4.4% midday after the company announced a deal to invest in Corning to add three new optical manufacturing plants in North Carolina and Texas, advancing its AI infrastructure push. The arrangement includes Nvidia’s option to invest up to $2.7 billion in Corning and warrants for up to 15 million Corning shares (exercise price $180) plus a pre-funded warrant for 3 million shares, continuing a string of optics-focused investments that began with earlier partnerships with Coherent and Lumentum. The move underscores Nvidia’s strategy to own more of the AI hardware supply chain as demand for faster, light-speed AI infrastructure grows.
Allbirds says it will shed its shoe business to become an AI-focused company named NewBird AI, selling its footwear assets for about $50 million and aiming to offer AI compute infrastructure, a move that sent its stock skyrocketing.
Allbirds says it is exiting footwear to become an AI compute company via a new entity named NewBird AI, after selling its IP/assets to American Exchange Group for $39 million two weeks earlier. NewBird AI plans to raise up to $50 million to acquire high-performance, low-latency AI hardware under long‑term leases, with a funding close expected in Q2 2026. American Exchange Group will continue to sell products under the Allbirds brand. Investors cheered the news, sending Allbirds’ shares up more than 300% in early trading and valuing the company around $20 million.
Hims & Hers Health stock jumped about 40% after Novo Nordisk announced it would distribute weight-loss medications on the Hims & Hers platform, signaling a potential major partnership and upside for the telehealth company.
ImmunityBio (IBRX) stock jumped over 30% after 2025 preliminary results showed Anktiva sales up about 700% year-over-year to roughly $113 million, with Q4 2025 revenue up 431% to $38.3 million. Regulatory wins expanding Anktiva’s reach include Saudi approvals for NSCLC combinations and for bladder cancer with BCG, while Phase 2b enrollment for first-line bladder cancer is progressing. Analysts sketch a bullish picture with a Strong Buy rating and a roughly $7.33 price target, implying substantial upside potential.
TSMC shares surged to a record high after Goldman Sachs raised its price target, driven by strong optimism over AI demand and the company's growth prospects, with analysts viewing AI as a multi-year growth engine for the chipmaker.
Fermi Inc. (NASDAQ:FRMI) surged 15.75% ahead of its upcoming business update and participation in the Evercore Power Conference, amid renewed optimism in the AI industry and recent developments in its data center operations, including a major tenant pullout and a new power supply agreement.
Super Micro's shares rose 5.7% after unveiling a new high-density server designed for AI and high-performance computing, featuring advanced cooling and increased computing power, amid a volatile market and shifting investor sentiment towards AI infrastructure stocks.
Intel's stock surged 7% following Nvidia's $5 billion investment and a U.S. Treasury stake, reflecting positive market sentiment about Intel's financial support and strategic partnership with Nvidia to develop advanced chips, though the stock remains highly volatile.
Micron's shares surged 8.1% after Bernstein raised its price target to $330, citing strong AI-driven demand for memory chips, especially DRAM, amid constrained supply and booming data center needs, following record quarterly results and optimistic forecasts.
Vertiv's shares soared 8.5% after Barclays upgraded the stock to 'Overweight' and raised its price target to $200, citing higher earnings estimates and potential inclusion in the S&P 500, amid overall market volatility and sector rotations.
Micron's stock surged over 10% after Bernstein analyst Mark Li raised his price target to $330, citing strong Q1 earnings with record revenue and margins, and optimistic forecasts for rising DRAM prices throughout 2026 driven by AI demand and data center growth.
Micron Technology hit an all-time high of $294.37 amid investor buying ahead of its dividend payout, following strong quarterly earnings that doubled net income to $5.24 billion and revenue of $13.6 billion, with future revenue guidance set higher at $18.7 billion.